Dendritic Killer Cell-based Immunotherapy for Solid Tumors

Clinical trial NCT02882659 · UNKNOWN

Trial details

NCT number: NCT02882659
Sponsor: FullHope Biomedical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Neoplasms Hepatocellular Carcinoma Neoplasm Metastasis

Start date: 2014-08-01
Primary completion: 2016-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.